Day 1 - March 2, 2009
08:30 - 09:00 | Breakfast/ Registration
09:00 - 09:30 | Welcoming Remarks
09:30 - 10:00 | Keynote Address: The Value of Vaccines - Till Bärnighausen
Session I: Global Pneumococcal Disease Epidemiology
Chairperson: Ciro de Quadros
10:00 - 10:30 | Pneumococcal disease and improving child survival - Orin Levine
10:30 - 10:45 | Break
Session II: Pneumococcal Epidemiology in the Region
Chairperson: Olu Akinyanju
10:45 - 11:00 | Pneumococcal Disease Burden in Africa
-Thomas Cherian
11:00 - 11:15 | Pneumococcal serotypes in Africa and the world - Hope Johnson
11:15 - 11:30 | HIV and Pneumococcal Disease - Shabir Madhi
11:30 - 11:45 | Sequelae due to Bacterial Meningitis in Africa - Fred Were
11:45 - 12:00 | Bacterial Infections in Persons with Sickle Cell Disease - Meena Ramakrishnan
12:00 - 12:30 | Discussion
12:30 - 13:30 | Lunch
Session III: Impact of Conjugate Pneumococcal Vaccines: Direct and Indirect Effects
Chairs: Jean-Marie Okwo-Bele and David Murdoch
13:30 - 13:45 | Review of Vaccine Trials in Africa – Gambia Experience - Richard Adegbola
13:45 - 14:00 | Review of Vaccine Trials in Africa – S. Africa Experience - Keith Klugman
14:00 - 14:15 | Pneumococcal vaccine: USA Experience - Cynthia Whitney
14:15 - 14:30 | Serotype Replacement in Perspective - Ron Dagan
14:30 - 14:45 | Discussion
14:45 - 15:00 | Break
Session IV: Issues in Conjugate Vaccination and Vaccine Development Update
Chairs: Keith Klugman and Cynthia Whitney
15:00 - 15:15 | Wyeth Existing and Upcoming Vaccines - Peter Paradiso
15:15 - 15:35 | GSK’s New Vaccine - William Hausdorff
15:35 - 15:50 | PATH Vaccine Development - Mark Alderson
15:50 - 16:05 | Emerging Market Vaccine Manufacturers - Akira Homma
16:05 - 16:30 | Discussion
16:30 - 16:45 | Parliamentarian’s Perspective - Jim Dobbin
16:45 - 17:00 | First Day Closing Remarks - Ciro de Quadros
17:15 - 19:00 | Welcome Cocktail
Day 2 – March 3, 2009
Session V: Global Introduction of Pneumococcal Vaccine
Chairs: Fred Were and Ron Dagan
09:00 - 09:30 | Cost-effectiveness of Vaccination - Anushua Sinha
09:30 - 10:00 | Status of Country Programs in Africa and WHO/AFRO Surveillance Plans - Deo Nshimirimana
10:00 - 10:40 | Discussion
10:40 - 11:00 | Break
Regional & Country Perspectives
Chairs: Thomas Cherian and Humphrey Lewis
11:00 - 11:15 | South Africa - Anne von Gottberg
11:15 - 11:30 | Mauritius - Mohammad Issack
11:30 - 11:45 | Democratic Republic of Congo - Michel Nyembwe
11:45 - 12:00 | Gambia - Richard Adegbola
12:00 - 12:15 | Burkina Faso/Togo - Judith Mueller
12:15 - 12:30 | Kenya - Tatu Kamau
12:30 - 13:15 | Discussion
13:15 - 14:15 | Lunch
Session VI: Vaccine Advocacy, Implementation Issues
Chairs: Deo Nshimirimana and Shabir Madhi
14:15 - 14:30 | PACE – Awareness Building for Pneumococcal Disease - Lulu Bravo
14:30 - 14:45 | The GAVI Alliance -Jon Pearman
14:45 - 15:15 | The Need for Accelerated Conjugate Pneumococcal Vaccination: A Call to Action in the region -Jean-Marie Okwo-Bele
15:15 - 15:45 | Discussion
15:45 - 16:00 | Closing Remarks
